Cargando…
Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide
CD138 expression is a hallmark of plasma cells and multiple myeloma cells. However, decreased expression of CD138 is frequently observed in plasma cells of myeloma patients, although the clinical significance of this is unclear. To evaluate the significance of low expression of CD138 in MM, we exami...
Autores principales: | KAWANO, YAWARA, FUJIWARA, SHIHO, WADA, NAOKO, IZAKI, MIKIKO, YUKI, HIROMICHI, OKUNO, YUTAKA, IYAMA, KENICHI, YAMASAKI, HIROSHI, SAKAI, AKIRA, MITSUYA, HIROAKI, HATA, HIROYUKI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582943/ https://www.ncbi.nlm.nih.gov/pubmed/22766978 http://dx.doi.org/10.3892/ijo.2012.1545 |
Ejemplares similares
-
Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells
por: KAWANO, YAWARA, et al.
Publicado: (2013) -
Lactate, a putative survival factor for myeloma cells, is incorporated by myeloma cells through monocarboxylate transporters 1
por: Fujiwara, Shiho, et al.
Publicado: (2015) -
Bufalin induces DNA damage response under hypoxic condition in myeloma cells
por: Fujii, Eri, et al.
Publicado: (2018) -
Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells
por: WADA, NAOKO, et al.
Publicado: (2014) -
PDK1 inhibition is a novel therapeutic target in multiple myeloma
por: Fujiwara, S, et al.
Publicado: (2013)